Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals.
JOURNAL OF INFECTIOUS DISEASES(2016)
摘要
We compared adjusted bone mineral density (BMD) changes between human immunodeficiency virus (HIV)-infected individuals during the first approximately 7.5 years after antiretroviral therapy (ART) initiation and HIV-uninfected controls. HIV-infected individuals (n = 97) had significantly greater adjusted BMD decline than controls (n = 614) during the first 96 weeks of ART. Subsequently, the rate of BMD decline slowed in HIV-infected individuals but remained greater than the rate of decline in HIV-uninfected individuals at the lumbar spine but not at the hip. In HIV-infected individuals after 96 weeks, no HIV- or treatment-related characteristic was associated with BMD loss, but lower lean body mass was associated with greater BMD loss at both lumbar spine and hip.
更多查看译文
关键词
anti-HIV agents,administration and dosage,adverse effects,HIV infections,drug therapy/virology,bone density
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络